已收盤 06-12 16:00:00 美东时间
-3.050
-10.06%
生物制药股NUVL涨超35%,获葛兰素史克高额溢价收购;支付公司Payoneer涨超33%,获加拿大支付公司Nuvei收购;超微电脑跌超26%,70亿美元的股权融资引市场忧虑>>
今天 09:46
临床阶段生物制药公司Parabilis Medicines本周完成了有史以来规模最大的风投支持生物科技首次公开募股,筹资约6.7亿美元,超出此前由Kail...
06-11 20:49
新股PBLS大涨58%,此前获10倍超购募资7.45亿美元;FAC大涨37%,近日完成SPAC合并登陆纳斯达克;凯西通用零售涨逾20%,Q4业绩超预期并大幅上调股息>>
06-11 16:35
雷递网 雷建平 6月11日 美国生物科技公司Parabilis Medicines(Nasdaq: PBLS)昨日在美国纳斯达克上市,发行价为20美元,发行3...
06-11 07:51
Parabilis Medicines (PBLS) climbed more than 45% in its first trading session on Wednesday after the cancer drug developer backed by a recent research deal with Regeneron (REGN) made its public debut ...
06-11 01:30
史上最大IPO定档!SpaceX将于6月12日正式上市;“青梅零食龙头”溜溜梅火热招股中,认购倍数逾75倍;“硬钢”OpenAI?Anthropic秘密递交IPO申请>>
06-05 17:42
UPDATE 1-Parabilis Medicines aims to raise up to $475 million in US IPO Adds details and context throughout June 4 (Reuters) - Biopharmaceutical company Parabilis Medicines said on Thursday it is aiming to raise as much as $475 million in its U.S. initial public offering. The summer IPO market has g
06-04 18:43
Parabilis Medicines aims to raise up to $475 million in US IPO June 4 (Reuters) - Biopharmaceutical company Parabilis Medicines said on Thursday it is aiming to raise as much as $475 million in its U.S. initial public offering. (Reporting by Manya Saini in Bengaluru; Editing by Shailesh Kuber) (( Ma
06-04 18:26